The risk of refusing a newborn’s vitamin K shot - Report - MDSpire

The risk of refusing a newborn’s vitamin K shot

  • By

  • Theresa Gaffney

  • July 14, 2026

Share

The Consequences of Declining Vitamin K Administration for Newborns

Overview

The decline in vitamin K administration for newborns has been documented, with a rise in the percentage of infants not receiving this prophylaxis.

Background

Vitamin K shots for newborns have been a standard preventive measure against VKDB for over 50 years. This deficiency can lead to severe complications, including intracranial hemorrhage.

Data Highlights

In Sweden, the rate of babies not receiving the vitamin K shot increased from 0.66% in 2006 to 1.5% in 2021. Infants who did not receive the shot had a higher risk of bleeding, including intracranial bleeding.

Key Findings

  • Prophylactic vitamin K shots are recommended for preventing VKDB in newborns.
  • Increased parental refusal of vitamin K shots correlates with rising rates of VKDB.
  • Infants without the vitamin K shot are at a higher risk of VKDB.
  • Recent studies show a trend in the decline of vitamin K administration among newborns.
  • Intracranial hemorrhage can occur due to vitamin K deficiency in infants.

Clinical Implications

Healthcare providers should inform new parents about vitamin K prophylaxis to prevent VKDB.

Conclusion

The decline in vitamin K administration for newborns is an issue that requires attention.

Related Resources & Content

  1. conexiant, Conexiant, 2026 -- Newborn Vitamin K Refusal Trends
  2. JAMA Network Open, JAMA Network, 2026 -- Parental Decline of Newborn Vitamin K and Hepatitis B Vaccine Administration by Newborn Sex
  3. Intensive Care Medicine, Springer, 2011 -- Intracranial Hemorrhage Linked to Vitamin K Deficiency: Benefits of Utilizing a Pediatric Intensive Care Database
  4. Recommendations | Intrapartum care | Guidance | NICE, NICE, 2026 -- Recommendations
  5. Trends in Vitamin K Administration Among Infants, JAMA, 2025 -- JAMA Network
  6. Journal of General Internal Medicine (Springer) — Severity of Gastrointestinal Bleeding in Anticoagulant Therapy with Vitamin K Antagonist or Direct Oral Anticoagulant Therapy
  7. Recommendations | Intrapartum care | Guidance | NICE
  8. Trends in Vitamin K Administration Among Infants | JAMA | JAMA Network

Original Source(s)

Related Content